As most previous large-scale studies on EGFR mutations primarily focused on adenocarcinoma, few studies have evaluated the frequency of EGFR mutations in non-adenocarcinoma NSCLC, such as squamous-cell carcinoma, adenosquamous carcinoma, and large-cell carcinoma. The gene discussed is EGFR; the disease is adenocarcinoma.